The Journal of Pediatrics
Volume 155, Issue 3 , Pages 369-373 , September 2009

Pramlintide Lowered Glucose Excursions and Was Well-Tolerated in Adolescents with Type 1 Diabetes: Results from a Randomized, Single-Blind, Placebo-Controlled, Crossover Study

  • H. Peter Chase, MD

      Affiliations

    • Barbara Davis Center for Childhood Diabetes, University of Colorado, Aurora, CO
    • Corresponding Author InformationReprint requests: H. Peter Chase, MD, Professor of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, PO Box 6511, 1775 Aurora Ct, Rm 1304, Aurora, CO 80045-6511.
  • ,
  • Karen Lutz, PhD

      Affiliations

    • Amylin Pharmaceuticals, Inc, San Diego, CA
  • ,
  • Richard Pencek, PhD

      Affiliations

    • Amylin Pharmaceuticals, Inc, San Diego, CA
  • ,
  • Bei Zhang, MD

      Affiliations

    • Amylin Pharmaceuticals, Inc, San Diego, CA
  • ,
  • Lisa Porter, MD

      Affiliations

    • Amylin Pharmaceuticals, Inc, San Diego, CA

Received 13 November 2008 ,Revised 5 February 2009 ,Accepted 13 March 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 H.P.C. has received research funding from Amylin Pharmaceuticals, Inc. K.L., R.P., B.Z., and L.P. are all employees and stockholders of Amylin Pharmaceuticals, Inc.

PII: S0022-3476(09)00245-5

doi: 10.1016/j.jpeds.2009.03.012

The Journal of Pediatrics
Volume 155, Issue 3 , Pages 369-373 , September 2009